Share Share this content Opens in a new window Opens in a new window Opens in a new window Opens in a new window OPA's Submission to Proposed Changes You may be interested in Nirmatrelvir/Ritonavir (Paxlovid) Prescribing December 12, 2022 Post category: Advocacy Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Advocacy Scope of Practice for Pharmacy Professionals April 10, 2023 Post category: Advocacy The Policies Impacting Pharmacy October 29, 2020 Post category: Advocacy
Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Advocacy
